These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 25399571)
1. Notch functions in developmental and tumour angiogenesis by diverse mechanisms. Kangsamaksin T; Tattersall IW; Kitajewski J Biochem Soc Trans; 2014 Dec; 42(6):1563-8. PubMed ID: 25399571 [TBL] [Abstract][Full Text] [Related]
2. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Kangsamaksin T; Murtomaki A; Kofler NM; Cuervo H; Chaudhri RA; Tattersall IW; Rosenstiel PE; Shawber CJ; Kitajewski J Cancer Discov; 2015 Feb; 5(2):182-97. PubMed ID: 25387766 [TBL] [Abstract][Full Text] [Related]
3. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis. Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984 [TBL] [Abstract][Full Text] [Related]
4. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Hellström M; Phng LK; Hofmann JJ; Wallgard E; Coultas L; Lindblom P; Alva J; Nilsson AK; Karlsson L; Gaiano N; Yoon K; Rossant J; Iruela-Arispe ML; Kalén M; Gerhardt H; Betsholtz C Nature; 2007 Feb; 445(7129):776-80. PubMed ID: 17259973 [TBL] [Abstract][Full Text] [Related]
5. Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis. Klose R; Berger C; Moll I; Adam MG; Schwarz F; Mohr K; Augustin HG; Fischer A Cardiovasc Res; 2015 Jul; 107(1):153-63. PubMed ID: 25975260 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323 [TBL] [Abstract][Full Text] [Related]
7. A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions. Zhu G; Lin Y; Ge T; Singh S; Liu H; Fan L; Wang S; Rhen J; Jiang D; Lyu Y; Yin Y; Li X; Benoit DSW; Li W; Xu Y; Pang J Br J Pharmacol; 2022 Apr; 179(8):1716-1731. PubMed ID: 34796471 [TBL] [Abstract][Full Text] [Related]
8. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis. Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447 [TBL] [Abstract][Full Text] [Related]
10. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis. Oon CE; Harris AL Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496 [TBL] [Abstract][Full Text] [Related]
11. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313 [TBL] [Abstract][Full Text] [Related]
12. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450 [TBL] [Abstract][Full Text] [Related]
13. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Funahashi Y; Hernandez SL; Das I; Ahn A; Huang J; Vorontchikhina M; Sharma A; Kanamaru E; Borisenko V; Desilva DM; Suzuki A; Wang X; Shawber CJ; Kandel JJ; Yamashiro DJ; Kitajewski J Cancer Res; 2008 Jun; 68(12):4727-35. PubMed ID: 18559519 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications. Li JL; Harris AL Front Biosci (Landmark Ed); 2009 Jan; 14(8):3094-110. PubMed ID: 19273260 [TBL] [Abstract][Full Text] [Related]
15. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth. Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154 [TBL] [Abstract][Full Text] [Related]
16. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Thurston G; Noguera-Troise I; Yancopoulos GD Nat Rev Cancer; 2007 May; 7(5):327-31. PubMed ID: 17457300 [TBL] [Abstract][Full Text] [Related]
19. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743 [TBL] [Abstract][Full Text] [Related]
20. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling. Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]